All In MedTech

Company

Becton Dickinson (BD)

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

Becton Dickinson (BD) is on our public-company list (ticker BDX). Names searched as well: Becton Dickinson, Becton, Dickinson, C.R. Bard, Bard Peripheral Vascular. Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements.

Public

Listed

BDX

NYSE · BECTON DICKINSON & CO

Public float

Unknown

Not reported in US filings

Revenue

$21.8B

Fiscal year ending Sep 30, 2025

Net income

$1.68B

Fiscal year ending Sep 30, 2025

R&D spending

$1.26B

Fiscal year ending Sep 30, 2025

Cash

$708M

As of Jun 30, 2026

Long-term debt

$13.5B

As of Jun 30, 2026

Shares outstanding

272.4M

As of Jun 30, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2024––$4.52B–
2023––$1.66B–
2022––$497M–
2021––$4.87B–

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

The investor database is part of the paid tier

For Becton Dickinson (BD) we have 4 shareholders with 5% or more.

It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

Latest FDA decisions

The 8 newest of 260 since 2015.

Search the Clearance Tracker

257 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar
  • NCT07798128 · 240 participants (planned) · Start Nov 6, 2026 · Primary completion Jun 30, 2027

    Device: PureWick™ Flex Female External Catheter (FFEC); Indwelling Urinary Catheter (IUC) · For: Urinary Incontinence; Limited Mobility

  • NCT07148323 · 100 participants (planned) · Start Oct 14, 2025 · Primary completion Nov 2026

    Device: HemoSphere Alta Monitor, Swan-Ganz IQ pulmonary arterial catheter, ForeSight IQ Large sensor, and Acumen IQ sensor · For: Hemodynamic Instability

    Sites: Rochester, New York

  • NCT06492746 · 120 participants (planned) · Start Jun 3, 2024 · Primary completion Jan 2027

    Device: HemoSphere Advanced Monitoring Platform with Acumen IQ sensor and Tissue Oximetry Monitoring · For: Blood Pressure

    Sites: Evanston, Illinois

41 more trials with a free account

Reports received

39,229

Received Nov 1, 2025 to Nov 20, 2026. Includes 26 of another or unstated type.

Malfunction reports

32,637

83% of reports

Injury reports

6,306

16% of reports

Death reports

260

0.7% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 232,29457241
Jan 241,99260671
Feb 242,10477870
Mar 242,11091031
Apr 242,13482573
May 242,3211,041101
Jun 242,24847221
Jul 242,35694391
Aug 242,36479061
Sep 242,134397100
Oct 242,33726352
Nov 242,47731324
Dec 242,99134021
Jan 252,42037070
Feb 252,77137180
Mar 252,751414140
Apr 253,10934891
May 252,70442920
Jun 253,12650241
Jul 254,41168862
Aug 255,469502103
Sep 256,474654141
Oct 252,951620170
Nov 253,492536240
Dec 252,855591254
Jan 262,388375190
Feb 262,816519130
Mar 262,626574290
Apr 262,739535163
May 262,315448191
Jun 262,414590290
Jul 262,744482123
Aug 262,4806453215
Sep 262,969451270
Oct 262,799560150
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

7 more in this ranking with a free account

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

7 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

1,044 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.